2006
DOI: 10.1016/j.ejphar.2005.11.038
|View full text |Cite
|
Sign up to set email alerts
|

Can P-glycoprotein influence the bioavailability of iminosugar-based glucosylceramide synthase inhibitors?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2007
2007
2011
2011

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 26 publications
1
1
0
Order By: Relevance
“…An increase in intracellular calcein fluorescence was also detected in the cells exposed to Genz-123346, indicating that Genz-123346 is a P-gp/MRP substrate. In contrast, C4DGJ and 5-FU did not affect intracellular calcein fluorescence, consistent with previous reports that these compounds are not P-gp substrates (25,35,37).…”
Section: The Ceramide-based Inhibitors Of Gcs (Pdmp and Genz-123346) supporting
confidence: 80%
See 1 more Smart Citation
“…An increase in intracellular calcein fluorescence was also detected in the cells exposed to Genz-123346, indicating that Genz-123346 is a P-gp/MRP substrate. In contrast, C4DGJ and 5-FU did not affect intracellular calcein fluorescence, consistent with previous reports that these compounds are not P-gp substrates (25,35,37).…”
Section: The Ceramide-based Inhibitors Of Gcs (Pdmp and Genz-123346) supporting
confidence: 80%
“…4C). Nevertheless, cellular drug accumulation in P-gp over-expressing NCI/ADR-RES cells treated with PDMP was not observed in previous studies (22,37). Therefore, the modulation of P-gp function by PDMP seems, at the very least, to be cell line-dependent.…”
Section: Discussionmentioning
confidence: 51%